GRAIL, Inc.
A biotech company that detects multiple cancers early with a single blood test.
GRAL | NDAQ
Overview
Corporate Details
- ISIN(s):
- US3847471014
- LEI:
- Country:
- United States of America
- Address:
- 1525 O'BRIEN DRIVE, 94025 MENLO PARK
- Website:
- https://grail.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
GRAIL, Inc. is a healthcare and biotechnology company dedicated to detecting cancer early, when it can be more effectively treated. The company's mission is to reduce the global burden of cancer by developing innovative diagnostic technologies. Its flagship product is the Galleri® test, a multi-cancer early detection (MCED) blood test designed to screen for a shared cancer signal across many cancer types, including those without recommended screening tests today. GRAIL utilizes a combination of next-generation sequencing (NGS), population-scale clinical studies, and advanced machine learning algorithms to develop its screening tools. The company's focus is on identifying cancers in their nascent stages, often before individuals become symptomatic, to improve patient outcomes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all GRAIL, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GRAIL, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GRAIL, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
